Ticker

N2OFF, Inc. (NASDAQ: NITO - Get Free Report) shares were up 5.4% on Tuesday. The stock traded as high as $1.00 and last traded at $0.9828. Approximately 42,228 shares changed hands during mid-day trading, a decline of 81% from the average daily volume of 222,978 shares. The stock had previously closed at $0.9324. N2OFF Stock

New identity reflects Company's evolution into an innovative data driven biotech company leveraging MITOLINE and mitochondrial carrier biology across oncology and inflammatory metabolic diseases Neve Yarak, Israel, Feb. 25, 2026 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) ("N2OFF" and the "Company"), a drug discovery company that is also investing in solar energy assets based on the RTB (Ready to Build) business…

Vancouver, British Columbia, February 19, 2026 – TheNewswire –  This press release is being disseminated as required b y National Instrument 62-103 The Early Warning System and Related Take-Over Bid and Insider Reporting Issues (“NI 62-103”). The requirement to provide this disclosure was triggered by an increase in Plantify Foods, Inc.'s (“ Plantify ”) issued and outstanding share capital on February 18, 2026, as a…

Neve Yarak, Israel, Feb. 02, 2026 (GLOBE NEWSWIRE) -- N2OFF, Inc. (NASDAQ: NITO) (“N2OFF” and the “Company”), a drug discovery company that is also investing in solar energy assets based on the  RTB (Ready to Build) business model, today highlighted a newly published peer-reviewed study co-authored by Prof. Ciro Leonardo Pierri, co-founder of MitoCareX Bio Ltd. (“MitoCareX Bio”), a specialty biotechnology company…

MITOLINE™ Algorithm Powers Development of First-in-Class Small Molecules Targeting a Mitochondrial Carrier for Inflammatory Metabolic Diseases – A Market Projected to Exceed $120 billion by 2030